

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug catabolic process (GO:0042737) | 8.32421857 |
| 2 | exogenous drug catabolic process (GO:0042738) | 8.31494823 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 8.06996420 |
| 4 | omega-hydroxylase P450 pathway (GO:0097267) | 7.75266922 |
| 5 | oxidative demethylation (GO:0070989) | 6.07618288 |
| 6 | drug metabolic process (GO:0017144) | 6.03864640 |
| 7 | blood coagulation, intrinsic pathway (GO:0007597) | 5.53918179 |
| 8 | glucuronate metabolic process (GO:0019585) | 5.38171690 |
| 9 | uronic acid metabolic process (GO:0006063) | 5.38171690 |
| 10 | serine family amino acid catabolic process (GO:0009071) | 5.35621942 |
| 11 | cellular glucuronidation (GO:0052695) | 5.27522674 |
| 12 | negative regulation of protein activation cascade (GO:2000258) | 4.90123107 |
| 13 | * phenylpropanoid metabolic process (GO:0009698) | 4.88334889 |
| 14 | S-adenosylmethionine metabolic process (GO:0046500) | 4.66377303 |
| 15 | glycine metabolic process (GO:0006544) | 4.59111365 |
| 16 | cellular ketone body metabolic process (GO:0046950) | 4.56598930 |
| 17 | negative regulation of cholesterol transport (GO:0032375) | 4.55323362 |
| 18 | negative regulation of sterol transport (GO:0032372) | 4.55323362 |
| 19 | regulation of plasminogen activation (GO:0010755) | 4.50523136 |
| 20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.43605507 |
| 21 | L-phenylalanine catabolic process (GO:0006559) | 4.43605507 |
| 22 | negative regulation of complement activation (GO:0045916) | 4.32024553 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 4.30267113 |
| 24 | imidazole-containing compound metabolic process (GO:0052803) | 4.24652658 |
| 25 | regulation of humoral immune response (GO:0002920) | 4.21544781 |
| 26 | L-phenylalanine metabolic process (GO:0006558) | 4.20874494 |
| 27 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.20874494 |
| 28 | alkaloid metabolic process (GO:0009820) | 4.19484235 |
| 29 | negative regulation of blood coagulation (GO:0030195) | 4.17235547 |
| 30 | negative regulation of hemostasis (GO:1900047) | 4.17235547 |
| 31 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.16360534 |
| 32 | bile acid biosynthetic process (GO:0006699) | 4.13175632 |
| 33 | aromatic amino acid family catabolic process (GO:0009074) | 4.12711767 |
| 34 | aldehyde catabolic process (GO:0046185) | 4.08738696 |
| 35 | complement activation, alternative pathway (GO:0006957) | 4.07818844 |
| 36 | response to nitrosative stress (GO:0051409) | 4.07083945 |
| 37 | arginine metabolic process (GO:0006525) | 4.03311400 |
| 38 | ketone body metabolic process (GO:1902224) | 4.02815102 |
| 39 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.01224368 |
| 40 | protein carboxylation (GO:0018214) | 4.01224368 |
| 41 | * xenobiotic catabolic process (GO:0042178) | 3.96318656 |
| 42 | alpha-amino acid catabolic process (GO:1901606) | 3.95728945 |
| 43 | indole-containing compound catabolic process (GO:0042436) | 3.91548189 |
| 44 | indolalkylamine catabolic process (GO:0046218) | 3.91548189 |
| 45 | tryptophan catabolic process (GO:0006569) | 3.91548189 |
| 46 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.90655871 |
| 47 | tryptophan metabolic process (GO:0006568) | 3.89949988 |
| 48 | glyoxylate metabolic process (GO:0046487) | 3.86749026 |
| 49 | serine family amino acid metabolic process (GO:0009069) | 3.84643579 |
| 50 | negative regulation of coagulation (GO:0050819) | 3.82380888 |
| 51 | negative regulation of wound healing (GO:0061045) | 3.81350890 |
| 52 | alpha-linolenic acid metabolic process (GO:0036109) | 3.79024695 |
| 53 | cytolysis (GO:0019835) | 3.76063599 |
| 54 | glutamate metabolic process (GO:0006536) | 3.72271276 |
| 55 | heme transport (GO:0015886) | 3.70868939 |
| 56 | high-density lipoprotein particle remodeling (GO:0034375) | 3.70054230 |
| 57 | regulation of protein activation cascade (GO:2000257) | 3.67739782 |
| 58 | hormone catabolic process (GO:0042447) | 3.65543612 |
| 59 | regulation of triglyceride catabolic process (GO:0010896) | 3.64697364 |
| 60 | urea metabolic process (GO:0019627) | 3.63659491 |
| 61 | urea cycle (GO:0000050) | 3.63659491 |
| 62 | complement activation, classical pathway (GO:0006958) | 3.62350682 |
| 63 | daunorubicin metabolic process (GO:0044597) | 3.56130439 |
| 64 | polyketide metabolic process (GO:0030638) | 3.56130439 |
| 65 | doxorubicin metabolic process (GO:0044598) | 3.56130439 |
| 66 | kynurenine metabolic process (GO:0070189) | 3.54354137 |
| 67 | intestinal cholesterol absorption (GO:0030299) | 3.52661069 |
| 68 | regulation of complement activation (GO:0030449) | 3.51739580 |
| 69 | cellular amino acid catabolic process (GO:0009063) | 3.50680511 |
| 70 | cysteine metabolic process (GO:0006534) | 3.49945743 |
| 71 | complement activation (GO:0006956) | 3.49715682 |
| 72 | * xenobiotic metabolic process (GO:0006805) | 3.48210770 |
| 73 | bile acid metabolic process (GO:0008206) | 3.47481598 |
| 74 | phospholipid efflux (GO:0033700) | 3.43466257 |
| 75 | valine metabolic process (GO:0006573) | 3.42075332 |
| 76 | plasma lipoprotein particle clearance (GO:0034381) | 3.41884609 |
| 77 | amino-acid betaine metabolic process (GO:0006577) | 3.39376346 |
| 78 | reverse cholesterol transport (GO:0043691) | 3.38620610 |
| 79 | steroid catabolic process (GO:0006706) | 3.38001615 |
| 80 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.37821849 |
| 81 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.37821849 |
| 82 | negative regulation of lipase activity (GO:0060192) | 3.34610073 |
| 83 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.32406979 |
| 84 | nitrogen cycle metabolic process (GO:0071941) | 3.32371159 |
| 85 | acute inflammatory response (GO:0002526) | 3.31546353 |
| 86 | regulation of cholesterol esterification (GO:0010872) | 3.30627690 |
| 87 | fatty acid beta-oxidation (GO:0006635) | 3.30337407 |
| 88 | negative regulation of fibrinolysis (GO:0051918) | 3.30101571 |
| 89 | plasma lipoprotein particle remodeling (GO:0034369) | 3.27274065 |
| 90 | protein-lipid complex remodeling (GO:0034368) | 3.27274065 |
| 91 | macromolecular complex remodeling (GO:0034367) | 3.27274065 |
| 92 | ethanol oxidation (GO:0006069) | 3.26598856 |
| 93 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.26129288 |
| 94 | fatty acid oxidation (GO:0019395) | 3.25833321 |
| 95 | protein activation cascade (GO:0072376) | 3.23303795 |
| 96 | regulation of fibrinolysis (GO:0051917) | 3.22595275 |
| 97 | lipid oxidation (GO:0034440) | 3.21698891 |
| 98 | * benzene-containing compound metabolic process (GO:0042537) | 3.19907601 |
| 99 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.18761045 |
| 100 | homocysteine metabolic process (GO:0050667) | 3.15933425 |
| 101 | flavonoid metabolic process (GO:0009812) | 3.14819572 |
| 102 | tyrosine metabolic process (GO:0006570) | 3.13389478 |
| 103 | positive regulation of lipid catabolic process (GO:0050996) | 3.10891615 |
| 104 | acylglycerol homeostasis (GO:0055090) | 3.10816810 |
| 105 | triglyceride homeostasis (GO:0070328) | 3.10816810 |
| 106 | cholesterol efflux (GO:0033344) | 3.09302896 |
| 107 | carnitine metabolic process (GO:0009437) | 3.06956901 |
| 108 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.05119175 |
| 109 | reactive oxygen species biosynthetic process (GO:1903409) | 3.03266341 |
| 110 | phospholipid homeostasis (GO:0055091) | 3.03203760 |
| 111 | fatty acid catabolic process (GO:0009062) | 3.01969496 |
| 112 | low-density lipoprotein particle remodeling (GO:0034374) | 2.99321019 |
| 113 | bile acid and bile salt transport (GO:0015721) | 2.99210148 |
| 114 | regulation of cholesterol metabolic process (GO:0090181) | 2.98990175 |
| 115 | acute-phase response (GO:0006953) | 2.96637669 |
| 116 | fibrinolysis (GO:0042730) | 2.96576825 |
| 117 | * monocarboxylic acid catabolic process (GO:0072329) | 2.96192561 |
| 118 | aromatic amino acid family metabolic process (GO:0009072) | 2.96157251 |
| 119 | L-ascorbic acid metabolic process (GO:0019852) | 2.88034064 |
| 120 | primary alcohol catabolic process (GO:0034310) | 2.87639047 |
| 121 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.86835678 |
| 122 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.86835678 |
| 123 | positive regulation of coagulation (GO:0050820) | 2.86618549 |
| 124 | indolalkylamine metabolic process (GO:0006586) | 2.85901487 |
| 125 | cellular biogenic amine catabolic process (GO:0042402) | 2.84243885 |
| 126 | amine catabolic process (GO:0009310) | 2.84243885 |
| 127 | ethanol metabolic process (GO:0006067) | 2.83185177 |
| 128 | positive regulation of hemostasis (GO:1900048) | 2.82118373 |
| 129 | positive regulation of blood coagulation (GO:0030194) | 2.82118373 |
| 130 | positive regulation of sterol transport (GO:0032373) | 2.80820880 |
| 131 | positive regulation of cholesterol transport (GO:0032376) | 2.80820880 |
| 132 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.80303792 |
| 133 | plasma lipoprotein particle assembly (GO:0034377) | 2.79966102 |
| 134 | cofactor catabolic process (GO:0051187) | 2.78953517 |
| 135 | glutathione derivative metabolic process (GO:1901685) | 2.77616966 |
| 136 | glutathione derivative biosynthetic process (GO:1901687) | 2.77616966 |
| 137 | negative regulation of lipid storage (GO:0010888) | 2.77533876 |
| 138 | regulation of sequestering of triglyceride (GO:0010889) | 2.74596367 |
| 139 | regulation of cholesterol storage (GO:0010885) | 2.73754468 |
| 140 | plasma lipoprotein particle organization (GO:0071827) | 2.73139359 |
| 141 | opsonization (GO:0008228) | 2.72283183 |
| 142 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.71287273 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.58087650 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.47018111 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.93378003 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.79606658 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.71686667 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.48814399 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.27618890 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.59436520 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.55134413 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.38379552 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.93949657 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.69641986 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.68520398 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.62894029 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.60284815 |
| 16 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.57233719 |
| 17 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.35303323 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.27833747 |
| 19 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.26522770 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 2.19833201 |
| 21 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.14214707 |
| 22 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.11961132 |
| 23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.10958468 |
| 24 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.08246685 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.07149268 |
| 26 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.07045301 |
| 27 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.01448170 |
| 28 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.01158123 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.98198945 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.95227049 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.93987551 |
| 32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.91298375 |
| 33 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.89773168 |
| 34 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.86017869 |
| 35 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.70829079 |
| 36 | VDR_22108803_ChIP-Seq_LS180_Human | 1.69040002 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.65821884 |
| 38 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.64134099 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.59935757 |
| 40 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.59298026 |
| 41 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.59201800 |
| 42 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.56351079 |
| 43 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.53307953 |
| 44 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.53034479 |
| 45 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.50418443 |
| 46 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.49399193 |
| 47 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.49074001 |
| 48 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.48027912 |
| 49 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.48027912 |
| 50 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.43387064 |
| 51 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.41856365 |
| 52 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.41519827 |
| 53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.39083781 |
| 54 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.38564544 |
| 55 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.37783115 |
| 56 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.37698223 |
| 57 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.35396302 |
| 58 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.35107931 |
| 59 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.33298850 |
| 60 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.33293347 |
| 61 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.30031482 |
| 62 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.29690024 |
| 63 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.28019965 |
| 64 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.27208224 |
| 65 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.26336831 |
| 66 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.26188773 |
| 67 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.23051334 |
| 68 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.22803421 |
| 69 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.21104706 |
| 70 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.20367455 |
| 71 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.20367455 |
| 72 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.19752209 |
| 73 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.16448878 |
| 74 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.16413652 |
| 75 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.15871626 |
| 76 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.15865666 |
| 77 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.15759440 |
| 78 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.13334967 |
| 79 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.12570554 |
| 80 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.12358485 |
| 81 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.12319872 |
| 82 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.11748134 |
| 83 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.11647710 |
| 84 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.11639070 |
| 85 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11131148 |
| 86 | * AR_20517297_ChIP-Seq_VCAP_Human | 1.09569355 |
| 87 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.09463637 |
| 88 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.08125996 |
| 89 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07662709 |
| 90 | STAT3_23295773_ChIP-Seq_U87_Human | 1.07401169 |
| 91 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.06284865 |
| 92 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.06178675 |
| 93 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.05017617 |
| 94 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.04987037 |
| 95 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.04951132 |
| 96 | P300_19829295_ChIP-Seq_ESCs_Human | 1.04661730 |
| 97 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04527971 |
| 98 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.04412333 |
| 99 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.04412333 |
| 100 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.03407293 |
| 101 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.03212720 |
| 102 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.01619277 |
| 103 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.01292908 |
| 104 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.01063108 |
| 105 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.00163618 |
| 106 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.99933780 |
| 107 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.98822933 |
| 108 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.98135581 |
| 109 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.98059266 |
| 110 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.96394751 |
| 111 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.95865703 |
| 112 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.95682738 |
| 113 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95357009 |
| 114 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95164530 |
| 115 | TCF4_23295773_ChIP-Seq_U87_Human | 0.94576014 |
| 116 | CBP_21632823_ChIP-Seq_H3396_Human | 0.94287676 |
| 117 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.94060191 |
| 118 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.93812510 |
| 119 | NFYA_21822215_ChIP-Seq_K562_Human | 0.92814364 |
| 120 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.92546008 |
| 121 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.92453567 |
| 122 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.92251307 |
| 123 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.91167591 |
| 124 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91099427 |
| 125 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.91062626 |
| 126 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90981257 |
| 127 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.90911554 |
| 128 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.90784709 |
| 129 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.90518061 |
| 130 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90268632 |
| 131 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.90196336 |
| 132 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90194014 |
| 133 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90163517 |
| 134 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.89745357 |
| 135 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.89648478 |
| 136 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.89585537 |
| 137 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.89202378 |
| 138 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.89162162 |
| 139 | CJUN_26792858_Chip-Seq_BT549_Human | 0.89143808 |
| 140 | NCOR_22424771_ChIP-Seq_293T_Human | 0.88904450 |
| 141 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.88882077 |
| 142 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.88166590 |
| 143 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.87564676 |
| 144 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.87254337 |
| 145 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.86970031 |
| 146 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.86496174 |
| 147 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86152658 |
| 148 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.86054545 |
| 149 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85644136 |
| 150 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.85145881 |
| 151 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84852630 |
| 152 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.84524614 |
| 153 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.83622097 |
| 154 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.80877359 |
| 155 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.79202616 |
| 156 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.78501574 |
| 157 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.78297569 |
| 158 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77851190 |
| 159 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.77360554 |
| 160 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.77340640 |
| 161 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.77271416 |
| 162 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.77271416 |
| 163 | GATA2_19941826_ChIP-Seq_K562_Human | 0.76440554 |
| 164 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.75615012 |
| 165 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.75468632 |
| 166 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.75272006 |
| 167 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73345743 |
| 168 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.72546188 |
| 169 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.72086145 |
| 170 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.71134403 |
| 171 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.70841325 |
| 172 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.70797653 |
| 173 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.70171345 |
| 174 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.67746963 |
| 175 | GATA3_26560356_Chip-Seq_TH2_Human | 0.66939411 |
| 176 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.65913845 |
| 177 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.65250462 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.24150416 |
| 2 | MP0008875_abnormal_xenobiotic_pharmacok | 4.33586927 |
| 3 | MP0005365_abnormal_bile_salt | 4.32471235 |
| 4 | MP0005360_urolithiasis | 4.29440116 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 4.26778676 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 2.93808455 |
| 7 | MP0010329_abnormal_lipoprotein_level | 2.80625848 |
| 8 | MP0003252_abnormal_bile_duct | 2.62183732 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.57809444 |
| 10 | MP0003186_abnormal_redox_activity | 2.48140385 |
| 11 | MP0009840_abnormal_foam_cell | 2.40225330 |
| 12 | MP0003195_calcinosis | 2.33181953 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.14856322 |
| 14 | MP0003724_increased_susceptibility_to | 2.08879710 |
| 15 | MP0005083_abnormal_biliary_tract | 2.05133653 |
| 16 | MP0005058_abnormal_lysosome_morphology | 1.93701429 |
| 17 | MP0003436_decreased_susceptibility_to | 1.91824521 |
| 18 | MP0001666_abnormal_nutrient_absorption | 1.84917141 |
| 19 | MP0004782_abnormal_surfactant_physiolog | 1.83385031 |
| 20 | MP0000609_abnormal_liver_physiology | 1.75118723 |
| 21 | MP0005332_abnormal_amino_acid | 1.74632545 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 1.66267306 |
| 23 | MP0005319_abnormal_enzyme/_coenzyme | 1.57556644 |
| 24 | MP0009785_altered_susceptibility_to | 1.56136821 |
| 25 | MP0005187_abnormal_penis_morphology | 1.53739501 |
| 26 | MP0001661_extended_life_span | 1.51947210 |
| 27 | MP0009697_abnormal_copulation | 1.51834253 |
| 28 | MP0002419_abnormal_innate_immunity | 1.51033801 |
| 29 | MP0004019_abnormal_vitamin_homeostasis | 1.51025954 |
| 30 | MP0009764_decreased_sensitivity_to | 1.50005320 |
| 31 | MP0008438_abnormal_cutaneous_collagen | 1.44334203 |
| 32 | MP0001764_abnormal_homeostasis | 1.41464642 |
| 33 | MP0005464_abnormal_platelet_physiology | 1.40583168 |
| 34 | MP0002138_abnormal_hepatobiliary_system | 1.38184867 |
| 35 | MP0002148_abnormal_hypersensitivity_rea | 1.35752881 |
| 36 | MP0006082_CNS_inflammation | 1.32492216 |
| 37 | MP0005408_hypopigmentation | 1.31286254 |
| 38 | MP0008469_abnormal_protein_level | 1.28146043 |
| 39 | MP0010368_abnormal_lymphatic_system | 1.27752573 |
| 40 | MP0005670_abnormal_white_adipose | 1.27252454 |
| 41 | MP0009643_abnormal_urine_homeostasis | 1.25472541 |
| 42 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.23418431 |
| 43 | MP0008872_abnormal_physiological_respon | 1.19277761 |
| 44 | MP0002132_abnormal_respiratory_system | 1.18920937 |
| 45 | MP0005025_abnormal_response_to | 1.18590064 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.18168757 |
| 47 | MP0002877_abnormal_melanocyte_morpholog | 1.17518446 |
| 48 | MP0003656_abnormal_erythrocyte_physiolo | 1.11366182 |
| 49 | MP0005636_abnormal_mineral_homeostasis | 1.08954083 |
| 50 | MP0009763_increased_sensitivity_to | 1.06001102 |
| 51 | MP0001845_abnormal_inflammatory_respons | 1.02714493 |
| 52 | MP0005000_abnormal_immune_tolerance | 0.99922071 |
| 53 | MP0002254_reproductive_system_inflammat | 0.99482924 |
| 54 | MP0008004_abnormal_stomach_pH | 0.98710803 |
| 55 | MP0008789_abnormal_olfactory_epithelium | 0.98596675 |
| 56 | MP0005647_abnormal_sex_gland | 0.97881043 |
| 57 | MP0000598_abnormal_liver_morphology | 0.97203342 |
| 58 | MP0005164_abnormal_response_to | 0.96319537 |
| 59 | MP0003690_abnormal_glial_cell | 0.95935270 |
| 60 | MP0003075_altered_response_to | 0.95923478 |
| 61 | MP0001790_abnormal_immune_system | 0.95794683 |
| 62 | MP0005387_immune_system_phenotype | 0.95794683 |
| 63 | MP0002166_altered_tumor_susceptibility | 0.95499874 |
| 64 | MP0002909_abnormal_adrenal_gland | 0.94823597 |
| 65 | MP0009780_abnormal_chondrocyte_physiolo | 0.93808050 |
| 66 | MP0002006_tumorigenesis | 0.93563925 |
| 67 | MP0005499_abnormal_olfactory_system | 0.93452591 |
| 68 | MP0005394_taste/olfaction_phenotype | 0.93452591 |
| 69 | MP0000343_altered_response_to | 0.93340785 |
| 70 | MP0001853_heart_inflammation | 0.92226885 |
| 71 | MP0004130_abnormal_muscle_cell | 0.90653015 |
| 72 | MP0002295_abnormal_pulmonary_circulatio | 0.89562558 |
| 73 | MP0002452_abnormal_antigen_presenting | 0.89051171 |
| 74 | MP0002078_abnormal_glucose_homeostasis | 0.88694276 |
| 75 | MP0003705_abnormal_hypodermis_morpholog | 0.88125488 |
| 76 | MP0010155_abnormal_intestine_physiology | 0.87567727 |
| 77 | MP0005166_decreased_susceptibility_to | 0.87297249 |
| 78 | MP0005395_other_phenotype | 0.87191082 |
| 79 | MP0003279_aneurysm | 0.86513493 |
| 80 | MP0005646_abnormal_pituitary_gland | 0.85731888 |
| 81 | MP0005334_abnormal_fat_pad | 0.84626781 |
| 82 | MP0003879_abnormal_hair_cell | 0.83975240 |
| 83 | MP0001958_emphysema | 0.82869367 |
| 84 | MP0002168_other_aberrant_phenotype | 0.82205443 |
| 85 | MP0005551_abnormal_eye_electrophysiolog | 0.80363180 |
| 86 | MP0002405_respiratory_system_inflammati | 0.79954864 |
| 87 | MP0010386_abnormal_urinary_bladder | 0.79206781 |
| 88 | MP0002876_abnormal_thyroid_physiology | 0.79161787 |
| 89 | MP0002998_abnormal_bone_remodeling | 0.78705595 |
| 90 | MP0005376_homeostasis/metabolism_phenot | 0.78567210 |
| 91 | MP0001879_abnormal_lymphatic_vessel | 0.77816623 |
| 92 | MP0004947_skin_inflammation | 0.77723603 |
| 93 | MP0002723_abnormal_immune_serum | 0.76837095 |
| 94 | MP0000249_abnormal_blood_vessel | 0.76742078 |
| 95 | MP0004883_abnormal_blood_vessel | 0.76568486 |
| 96 | MP0005451_abnormal_body_composition | 0.76215535 |
| 97 | MP0001800_abnormal_humoral_immune | 0.75644667 |
| 98 | MP0009642_abnormal_blood_homeostasis | 0.75057089 |
| 99 | MP0002060_abnormal_skin_morphology | 0.75024260 |
| 100 | MP0002971_abnormal_brown_adipose | 0.73802596 |
| 101 | MP0000685_abnormal_immune_system | 0.73642468 |
| 102 | MP0001944_abnormal_pancreas_morphology | 0.73236346 |
| 103 | MP0003638_abnormal_response/metabolism_ | 0.72330841 |
| 104 | MP0002282_abnormal_trachea_morphology | 0.72273176 |
| 105 | MP0003868_abnormal_feces_composition | 0.72017771 |
| 106 | MP0003011_delayed_dark_adaptation | 0.71881563 |
| 107 | MP0002933_joint_inflammation | 0.71616805 |
| 108 | MP0005671_abnormal_response_to | 0.71597216 |
| 109 | MP0003300_gastrointestinal_ulcer | 0.70324072 |
| 110 | MP0005535_abnormal_body_temperature | 0.69264760 |
| 111 | MP0001984_abnormal_olfaction | 0.68286106 |
| 112 | MP0002136_abnormal_kidney_physiology | 0.68192744 |
| 113 | MP0005666_abnormal_adipose_tissue | 0.68168867 |
| 114 | MP0005220_abnormal_exocrine_pancreas | 0.67355756 |
| 115 | MP0005084_abnormal_gallbladder_morpholo | 0.66941401 |
| 116 | MP0009384_cardiac_valve_regurgitation | 0.66903412 |
| 117 | MP0006036_abnormal_mitochondrial_physio | 0.64069342 |
| 118 | MP0005645_abnormal_hypothalamus_physiol | 0.63695050 |
| 119 | MP0002090_abnormal_vision | 0.60567860 |
| 120 | MP0005379_endocrine/exocrine_gland_phen | 0.59244487 |
| 121 | MP0005266_abnormal_metabolism | 0.57885085 |
| 122 | MP0002928_abnormal_bile_duct | 0.57049666 |
| 123 | MP0003122_maternal_imprinting | 0.56849332 |
| 124 | MP0001756_abnormal_urination | 0.55784218 |
| 125 | MP0003953_abnormal_hormone_level | 0.54801621 |
| 126 | MP0005448_abnormal_energy_balance | 0.53939920 |
| 127 | MP0002938_white_spotting | 0.52284341 |
| 128 | MP0004043_abnormal_pH_regulation | 0.51394637 |
| 129 | MP0009053_abnormal_anal_canal | 0.49304359 |
| 130 | MP0000639_abnormal_adrenal_gland | 0.47468775 |
| 131 | MP0000604_amyloidosis | 0.47258066 |
| 132 | MP0003718_maternal_effect | 0.44290989 |
| 133 | MP0008877_abnormal_DNA_methylation | 0.41890415 |
| 134 | MP0001501_abnormal_sleep_pattern | 0.38354526 |
| 135 | MP0005386_behavior/neurological_phenoty | 0.38176633 |
| 136 | MP0004924_abnormal_behavior | 0.38176633 |
| 137 | MP0001915_intracranial_hemorrhage | 0.37936497 |
| 138 | MP0002693_abnormal_pancreas_physiology | 0.37672827 |
| 139 | MP0006072_abnormal_retinal_apoptosis | 0.37109663 |
| 140 | MP0000566_synostosis | 0.35632946 |
| 141 | MP0003633_abnormal_nervous_system | 0.34738219 |
| 142 | MP0003878_abnormal_ear_physiology | 0.34623248 |
| 143 | MP0005377_hearing/vestibular/ear_phenot | 0.34623248 |
| 144 | MP0001986_abnormal_taste_sensitivity | 0.34493204 |
| 145 | MP0001485_abnormal_pinna_reflex | 0.34452985 |
| 146 | MP0004133_heterotaxia | 0.34360739 |
| 147 | MP0003283_abnormal_digestive_organ | 0.33355165 |
| 148 | MP0009745_abnormal_behavioral_response | 0.31921171 |
| 149 | MP0001324_abnormal_eye_pigmentation | 0.31429020 |
| 150 | MP0003787_abnormal_imprinting | 0.30862480 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 4.72133849 |
| 2 | Complement deficiency (HP:0004431) | 4.70026018 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.69753556 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.66091995 |
| 5 | Deep venous thrombosis (HP:0002625) | 4.46409893 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.36281897 |
| 7 | Xanthomatosis (HP:0000991) | 4.29521983 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 4.21604382 |
| 9 | Abnormality of complement system (HP:0005339) | 3.95796935 |
| 10 | Joint hemorrhage (HP:0005261) | 3.94097220 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.89845411 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 3.56702582 |
| 13 | Abnormality of the intrinsic pathway (HP:0010989) | 3.56583718 |
| 14 | Hypobetalipoproteinemia (HP:0003563) | 3.54854840 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 3.51761950 |
| 16 | Hypoglycemic coma (HP:0001325) | 3.47634788 |
| 17 | Fat malabsorption (HP:0002630) | 3.32180366 |
| 18 | Myocardial infarction (HP:0001658) | 3.30480454 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 3.28333338 |
| 20 | Vacuolated lymphocytes (HP:0001922) | 3.24760843 |
| 21 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.24103434 |
| 22 | Epidermoid cyst (HP:0200040) | 3.22597581 |
| 23 | Hypolipoproteinemia (HP:0010981) | 3.21109761 |
| 24 | Glomerulonephritis (HP:0000099) | 3.15150882 |
| 25 | Hyperammonemia (HP:0001987) | 3.11222888 |
| 26 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.07278892 |
| 27 | Hypercholesterolemia (HP:0003124) | 3.05206972 |
| 28 | Eczematoid dermatitis (HP:0000976) | 3.01403151 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 2.94783510 |
| 30 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.90093490 |
| 31 | Steatorrhea (HP:0002570) | 2.89171428 |
| 32 | Hyperglycinuria (HP:0003108) | 2.87263030 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.84724966 |
| 34 | Generalized aminoaciduria (HP:0002909) | 2.79788825 |
| 35 | Fair hair (HP:0002286) | 2.77161454 |
| 36 | Recurrent bacterial skin infections (HP:0005406) | 2.76717582 |
| 37 | Recurrent abscess formation (HP:0002722) | 2.66388897 |
| 38 | Ketosis (HP:0001946) | 2.65071002 |
| 39 | Axonal loss (HP:0003447) | 2.60336119 |
| 40 | Abnormality of methionine metabolism (HP:0010901) | 2.59542583 |
| 41 | Hypothermia (HP:0002045) | 2.56460030 |
| 42 | Hyperbilirubinemia (HP:0002904) | 2.54242790 |
| 43 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.54236958 |
| 44 | Hyperglycinemia (HP:0002154) | 2.51288117 |
| 45 | Hepatocellular carcinoma (HP:0001402) | 2.50575550 |
| 46 | Renal cortical cysts (HP:0000803) | 2.49525467 |
| 47 | Hypoglycemic seizures (HP:0002173) | 2.44717267 |
| 48 | Hyperglycemia (HP:0003074) | 2.43978504 |
| 49 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.43630851 |
| 50 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.43178432 |
| 51 | Abnormality of glycine metabolism (HP:0010895) | 2.43178432 |
| 52 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.42585299 |
| 53 | Mucopolysacchariduria (HP:0008155) | 2.42585299 |
| 54 | Glycosuria (HP:0003076) | 2.40890823 |
| 55 | Abnormality of urine glucose concentration (HP:0011016) | 2.40890823 |
| 56 | Gingival bleeding (HP:0000225) | 2.39026601 |
| 57 | Osteomalacia (HP:0002749) | 2.34836596 |
| 58 | Vascular calcification (HP:0004934) | 2.34267604 |
| 59 | Nephritis (HP:0000123) | 2.34084774 |
| 60 | Hyperphosphaturia (HP:0003109) | 2.30647132 |
| 61 | Proximal tubulopathy (HP:0000114) | 2.29880374 |
| 62 | Nausea (HP:0002018) | 2.29447856 |
| 63 | Rickets (HP:0002748) | 2.27030935 |
| 64 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.26631115 |
| 65 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.26631115 |
| 66 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.26631115 |
| 67 | Arthropathy (HP:0003040) | 2.24408055 |
| 68 | Interstitial pulmonary disease (HP:0006530) | 2.23667772 |
| 69 | Dysostosis multiplex (HP:0000943) | 2.23535291 |
| 70 | Amyloidosis (HP:0011034) | 2.20797726 |
| 71 | Esophageal varix (HP:0002040) | 2.20605529 |
| 72 | Dicarboxylic aciduria (HP:0003215) | 2.20419024 |
| 73 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.20419024 |
| 74 | Cardiovascular calcification (HP:0011915) | 2.19863945 |
| 75 | Ketoacidosis (HP:0001993) | 2.18553715 |
| 76 | Abnormal cartilage morphology (HP:0002763) | 2.18236276 |
| 77 | Menorrhagia (HP:0000132) | 2.16862798 |
| 78 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.16540725 |
| 79 | Abnormality of vitamin metabolism (HP:0100508) | 2.15581403 |
| 80 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.14387502 |
| 81 | Pancreatitis (HP:0001733) | 2.12651154 |
| 82 | Mitral stenosis (HP:0001718) | 2.12475355 |
| 83 | Cerebral palsy (HP:0100021) | 2.09804532 |
| 84 | Abnormality of nucleobase metabolism (HP:0010932) | 2.08388940 |
| 85 | Hypertriglyceridemia (HP:0002155) | 2.07919157 |
| 86 | Abnormality of purine metabolism (HP:0004352) | 2.05389659 |
| 87 | Periodontitis (HP:0000704) | 2.03326535 |
| 88 | Abnormality of macrophages (HP:0004311) | 2.03080203 |
| 89 | Metabolic acidosis (HP:0001942) | 2.02889860 |
| 90 | Beaking of vertebral bodies (HP:0004568) | 2.00319343 |
| 91 | Abnormal biliary tract physiology (HP:0012439) | 1.99580910 |
| 92 | Bile duct proliferation (HP:0001408) | 1.99580910 |
| 93 | Skin nodule (HP:0200036) | 1.99558654 |
| 94 | Generalized hypopigmentation of hair (HP:0011358) | 1.99450209 |
| 95 | Abnormality of proline metabolism (HP:0010907) | 1.97626452 |
| 96 | Hydroxyprolinuria (HP:0003080) | 1.97626452 |
| 97 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.97402573 |
| 98 | Osteolytic defects of the hand bones (HP:0009699) | 1.97402573 |
| 99 | Irritability (HP:0000737) | 1.93933154 |
| 100 | Reduced antithrombin III activity (HP:0001976) | 1.92307585 |
| 101 | Abnormal tarsal ossification (HP:0008369) | 1.90595740 |
| 102 | Blue irides (HP:0000635) | 1.87211656 |
| 103 | Epistaxis (HP:0000421) | 1.85686612 |
| 104 | Opisthotonus (HP:0002179) | 1.85428706 |
| 105 | Autoimmune thrombocytopenia (HP:0001973) | 1.82869715 |
| 106 | Nonimmune hydrops fetalis (HP:0001790) | 1.82621854 |
| 107 | Purpura (HP:0000979) | 1.82541586 |
| 108 | Pulmonary embolism (HP:0002204) | 1.82075746 |
| 109 | Neonatal hypoglycemia (HP:0001998) | 1.78973180 |
| 110 | Spontaneous abortion (HP:0005268) | 1.78396860 |
| 111 | Thrombophlebitis (HP:0004418) | 1.78177446 |
| 112 | Cerebral edema (HP:0002181) | 1.77902101 |
| 113 | Abnormality of serum amino acid levels (HP:0003112) | 1.77333216 |
| 114 | Renal tubular acidosis (HP:0001947) | 1.76547309 |
| 115 | Hemorrhage of the eye (HP:0011885) | 1.75396154 |
| 116 | Delayed CNS myelination (HP:0002188) | 1.74705756 |
| 117 | Respiratory distress (HP:0002098) | 1.74432096 |
| 118 | Abnormal urine phosphate concentration (HP:0012599) | 1.73785036 |
| 119 | Lethargy (HP:0001254) | 1.73039711 |
| 120 | Increased serum pyruvate (HP:0003542) | 1.71285550 |
| 121 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.71194683 |
| 122 | Hepatosplenomegaly (HP:0001433) | 1.70798126 |
| 123 | Increased mean platelet volume (HP:0011877) | 1.70333939 |
| 124 | Enlarged kidneys (HP:0000105) | 1.68953553 |
| 125 | Bifid scrotum (HP:0000048) | 1.66059391 |
| 126 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.64701947 |
| 127 | Abnormal gallbladder morphology (HP:0012437) | 1.64391880 |
| 128 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.62557934 |
| 129 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.62557934 |
| 130 | Hypophosphatemic rickets (HP:0004912) | 1.62554900 |
| 131 | Retinal atrophy (HP:0001105) | 1.60045241 |
| 132 | Alkalosis (HP:0001948) | 1.58708835 |
| 133 | Late onset (HP:0003584) | 1.55142878 |
| 134 | Abnormality of iron homeostasis (HP:0011031) | 1.54289995 |
| 135 | Joint swelling (HP:0001386) | 1.53320150 |
| 136 | Cholelithiasis (HP:0001081) | 1.46906102 |
| 137 | Abnormality of glycolysis (HP:0004366) | 1.46884624 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.24128032 |
| 2 | BCKDK | 3.14896046 |
| 3 | PINK1 | 3.08478717 |
| 4 | MAP3K14 | 2.96267500 |
| 5 | TGFBR2 | 2.80153157 |
| 6 | NTRK3 | 2.64279364 |
| 7 | FRK | 2.61498882 |
| 8 | MAP4K2 | 2.35458235 |
| 9 | ZAK | 2.30284462 |
| 10 | WNK3 | 2.22694650 |
| 11 | MAP3K3 | 2.22449303 |
| 12 | MST1R | 2.15858415 |
| 13 | NEK9 | 2.14545632 |
| 14 | TBK1 | 2.12760993 |
| 15 | FER | 2.08276418 |
| 16 | TYK2 | 2.06772324 |
| 17 | IRAK3 | 2.00679031 |
| 18 | INSRR | 1.86041757 |
| 19 | TAOK3 | 1.82289781 |
| 20 | BLK | 1.75787579 |
| 21 | FGFR4 | 1.75599686 |
| 22 | IKBKE | 1.74805799 |
| 23 | MAP2K3 | 1.73215811 |
| 24 | PBK | 1.72002316 |
| 25 | ERBB3 | 1.70604126 |
| 26 | PIK3CG | 1.68391921 |
| 27 | TEC | 1.66590434 |
| 28 | FGFR2 | 1.64910450 |
| 29 | PAK3 | 1.64269977 |
| 30 | CASK | 1.63656310 |
| 31 | BMPR2 | 1.62657590 |
| 32 | IRAK4 | 1.58470470 |
| 33 | SIK1 | 1.56221498 |
| 34 | JAK1 | 1.50133933 |
| 35 | PRKCG | 1.46146512 |
| 36 | KIT | 1.42590742 |
| 37 | MAP3K4 | 1.41323285 |
| 38 | STK38L | 1.37724704 |
| 39 | TNK2 | 1.34282069 |
| 40 | TRPM7 | 1.30479643 |
| 41 | MAPK15 | 1.27090942 |
| 42 | DAPK2 | 1.26581947 |
| 43 | IKBKB | 1.25679524 |
| 44 | MAP4K1 | 1.25347720 |
| 45 | PRKCE | 1.24139748 |
| 46 | TXK | 1.19302834 |
| 47 | PDK2 | 1.18784466 |
| 48 | RIPK1 | 1.18034699 |
| 49 | STK39 | 1.13311734 |
| 50 | AKT3 | 1.13229645 |
| 51 | TIE1 | 1.11909051 |
| 52 | PRKACG | 1.09207171 |
| 53 | FLT3 | 1.08245428 |
| 54 | PIK3CA | 1.08085204 |
| 55 | FGFR3 | 1.06611359 |
| 56 | JAK2 | 1.06271050 |
| 57 | TRIB3 | 1.05837417 |
| 58 | PIM2 | 1.04184615 |
| 59 | GRK7 | 1.03719607 |
| 60 | MST4 | 1.03005935 |
| 61 | RIPK4 | 1.01974294 |
| 62 | ZAP70 | 0.99835632 |
| 63 | JAK3 | 0.99212970 |
| 64 | EPHA3 | 0.98925251 |
| 65 | CSF1R | 0.98551644 |
| 66 | BTK | 0.98542297 |
| 67 | CAMK1D | 0.98213394 |
| 68 | MAP3K12 | 0.96782799 |
| 69 | CHUK | 0.96424337 |
| 70 | OXSR1 | 0.93917285 |
| 71 | ACVR1B | 0.92118376 |
| 72 | PHKG2 | 0.91241733 |
| 73 | PHKG1 | 0.91241733 |
| 74 | EPHA2 | 0.90233266 |
| 75 | NME2 | 0.90233155 |
| 76 | WNK4 | 0.87511676 |
| 77 | ABL2 | 0.85000480 |
| 78 | STK10 | 0.84948873 |
| 79 | PRKG1 | 0.82496766 |
| 80 | PRKACA | 0.80305126 |
| 81 | CSK | 0.79685482 |
| 82 | MAPK11 | 0.79574785 |
| 83 | BRSK2 | 0.79357059 |
| 84 | TRIM28 | 0.79113680 |
| 85 | MAPKAPK3 | 0.78230556 |
| 86 | PKN2 | 0.78038055 |
| 87 | MAP2K6 | 0.77607882 |
| 88 | ERBB4 | 0.77017531 |
| 89 | PRKG2 | 0.76652257 |
| 90 | TNIK | 0.75357182 |
| 91 | LYN | 0.74645648 |
| 92 | EPHA4 | 0.74446228 |
| 93 | CDK6 | 0.73703006 |
| 94 | CSNK1G1 | 0.73410607 |
| 95 | KDR | 0.73359326 |
| 96 | PRKAA1 | 0.72645517 |
| 97 | MYLK | 0.72458960 |
| 98 | STK4 | 0.72028621 |
| 99 | NLK | 0.71713023 |
| 100 | ADRBK2 | 0.70056160 |
| 101 | PRKCI | 0.69925526 |
| 102 | LATS1 | 0.69657994 |
| 103 | MAP2K4 | 0.69497238 |
| 104 | EIF2AK2 | 0.69027345 |
| 105 | MAP3K2 | 0.68046306 |
| 106 | PRKACB | 0.65211487 |
| 107 | NUAK1 | 0.64639080 |
| 108 | ITK | 0.64182482 |
| 109 | RPS6KA4 | 0.64038862 |
| 110 | CAMK2D | 0.63761020 |
| 111 | PTK6 | 0.62886709 |
| 112 | MKNK2 | 0.61500728 |
| 113 | SGK3 | 0.61105808 |
| 114 | MAP3K10 | 0.60150650 |
| 115 | PNCK | 0.60059487 |
| 116 | PIM1 | 0.59343650 |
| 117 | CSNK1D | 0.59139307 |
| 118 | MAP3K11 | 0.58732698 |
| 119 | SGK2 | 0.57879373 |
| 120 | MATK | 0.57670435 |
| 121 | MAPK13 | 0.57428896 |
| 122 | PRKAA2 | 0.55259620 |
| 123 | BCR | 0.54865088 |
| 124 | STK3 | 0.54790049 |
| 125 | ADRBK1 | 0.54306270 |
| 126 | SYK | 0.53750293 |
| 127 | GRK1 | 0.53607410 |
| 128 | CSNK1A1 | 0.52445394 |
| 129 | EIF2AK1 | 0.51838318 |
| 130 | PRKCZ | 0.51652453 |
| 131 | PRKCA | 0.51368955 |
| 132 | IGF1R | 0.51152383 |
| 133 | PRKCD | 0.51080276 |
| 134 | MAP2K7 | 0.49038278 |
| 135 | IRAK1 | 0.47970801 |
| 136 | EPHB1 | 0.47968105 |
| 137 | DYRK2 | 0.47657721 |
| 138 | BMPR1B | 0.47593003 |
| 139 | EPHB2 | 0.47405687 |
| 140 | MAP2K1 | 0.44852903 |
| 141 | CSNK1G2 | 0.44844873 |
| 142 | RPS6KB2 | 0.43718952 |
| 143 | MAPK7 | 0.43691834 |
| 144 | RPS6KA6 | 0.43198474 |
| 145 | CSNK1G3 | 0.42620068 |
| 146 | PTK2B | 0.42319003 |
| 147 | PDPK1 | 0.41852020 |
| 148 | PLK2 | 0.40304791 |
| 149 | ERBB2 | 0.40285005 |
| 150 | MET | 0.40237160 |
| 151 | ABL1 | 0.40068298 |
| 152 | EIF2AK3 | 0.39262285 |
| 153 | GSK3A | 0.39196732 |
| 154 | CSNK1E | 0.38833197 |
| 155 | LRRK2 | 0.38535654 |
| 156 | CSNK1A1L | 0.37297305 |
| 157 | PRKCB | 0.37052983 |
| 158 | STK38 | 0.36623612 |
| 159 | PTK2 | 0.34508859 |
| 160 | MUSK | 0.33161602 |
| 161 | FGFR1 | 0.31819414 |
| 162 | LIMK1 | 0.31596483 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.73335553 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.69160088 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.51959369 |
| 4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.89378291 |
| 5 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.71679161 |
| 6 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.56546726 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.54636110 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.52344868 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.48372092 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.35316522 |
| 11 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.24862526 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.07532080 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.04742506 |
| 14 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.00925141 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 1.95578388 |
| 16 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.92763996 |
| 17 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.91131840 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.89724826 |
| 19 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.84633384 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.81000099 |
| 21 | Retinol metabolism_Homo sapiens_hsa00830 | 1.78708007 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.72070228 |
| 23 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.71552971 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.68391872 |
| 25 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.67004840 |
| 26 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.61819481 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.60740202 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.56137329 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.56051506 |
| 30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.52065376 |
| 31 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.45676099 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.44015188 |
| 33 | Sulfur relay system_Homo sapiens_hsa04122 | 1.41832947 |
| 34 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.40015088 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.28910948 |
| 36 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.27603511 |
| 37 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.27145093 |
| 38 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26891196 |
| 39 | ABC transporters_Homo sapiens_hsa02010 | 1.25976323 |
| 40 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.20684653 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.18972363 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.10040221 |
| 43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.09486626 |
| 44 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.05323245 |
| 45 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.00437444 |
| 46 | Other glycan degradation_Homo sapiens_hsa00511 | 1.00178301 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.97202664 |
| 48 | Legionellosis_Homo sapiens_hsa05134 | 0.93218320 |
| 49 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.89566643 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.85478736 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.83577316 |
| 52 | Galactose metabolism_Homo sapiens_hsa00052 | 0.83162223 |
| 53 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.83102821 |
| 54 | Lysosome_Homo sapiens_hsa04142 | 0.82526883 |
| 55 | Leishmaniasis_Homo sapiens_hsa05140 | 0.79987818 |
| 56 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.79907842 |
| 57 | Pertussis_Homo sapiens_hsa05133 | 0.76445107 |
| 58 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.74896811 |
| 59 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.73492957 |
| 60 | Protein export_Homo sapiens_hsa03060 | 0.73351983 |
| 61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.72425452 |
| 62 | Carbon metabolism_Homo sapiens_hsa01200 | 0.71980937 |
| 63 | Bile secretion_Homo sapiens_hsa04976 | 0.70438283 |
| 64 | Malaria_Homo sapiens_hsa05144 | 0.68959974 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.62283798 |
| 66 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.62034711 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61556614 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60222449 |
| 69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.59200614 |
| 70 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.58535707 |
| 71 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.55226312 |
| 72 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.53712381 |
| 73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52368844 |
| 74 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.52006726 |
| 75 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.50486163 |
| 76 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.49160288 |
| 77 | Prion diseases_Homo sapiens_hsa05020 | 0.47597145 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.47448640 |
| 79 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.46055784 |
| 80 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.44960535 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.44878189 |
| 82 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.43070049 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42435594 |
| 84 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.42244416 |
| 85 | Tuberculosis_Homo sapiens_hsa05152 | 0.41022497 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.40402523 |
| 87 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39387373 |
| 88 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38404146 |
| 89 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.38023244 |
| 90 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.38018447 |
| 91 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.35646513 |
| 92 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.34955372 |
| 93 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.34824043 |
| 94 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.34184879 |
| 95 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.34116143 |
| 96 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.33026982 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.32209670 |
| 98 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.32079009 |
| 99 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.31009138 |
| 100 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.26584922 |
| 101 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.26458458 |
| 102 | Lysine degradation_Homo sapiens_hsa00310 | 0.21111052 |
| 103 | Mineral absorption_Homo sapiens_hsa04978 | 0.20876661 |
| 104 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.20576744 |
| 105 | Hepatitis C_Homo sapiens_hsa05160 | 0.20553013 |
| 106 | Influenza A_Homo sapiens_hsa05164 | 0.20513558 |
| 107 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.19050289 |
| 108 | Measles_Homo sapiens_hsa05162 | 0.18914239 |
| 109 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.18631616 |
| 110 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.14282414 |
| 111 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.10977249 |
| 112 | Circadian rhythm_Homo sapiens_hsa04710 | 0.06795365 |
| 113 | Insulin secretion_Homo sapiens_hsa04911 | 0.04392081 |
| 114 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.02880532 |
| 115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.02876986 |
| 116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.02447146 |
| 117 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.02380301 |
| 118 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1043207 |
| 119 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1018877 |
| 120 | Phototransduction_Homo sapiens_hsa04744 | -0.0966296 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0950648 |
| 122 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.0925585 |
| 123 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0869748 |
| 124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0471161 |
| 125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0425238 |
| 126 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0330947 |
| 127 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0169783 |

